Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,041
-3.42%
|
$77,558
$38.71 P/Share
|
|
Mar 17
2025
|
Xiaolin Wang |
SELL
Bona fide gift
|
Direct |
2,718
-2.59%
|
-
|
|
Mar 17
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,294
-1.11%
|
$128,466
$39.04 P/Share
|
|
Mar 17
2025
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,058
-1.95%
|
$119,262
$39.04 P/Share
|
|
Mar 17
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,864
-1.59%
|
$72,696
$39.04 P/Share
|
|
Mar 17
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
11,738
-2.59%
|
$457,782
$39.04 P/Share
|
|
Mar 17
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,458
-2.38%
|
$56,862
$39.04 P/Share
|
|
Mar 01
2025
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
97,400
+17.69%
|
-
|
|
Mar 01
2025
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+15.32%
|
-
|
|
Mar 01
2025
|
Lin Wei Chief Medical Officer |
SELL
Grant, award, or other acquisition
|
Direct |
20,800
-18.5%
|
-
|
|
Mar 01
2025
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,600
+15.44%
|
-
|
|
Mar 01
2025
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
36,600
+10.99%
|
-
|
|
Mar 01
2025
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,400
+14.86%
|
-
|
|
Mar 01
2025
|
Jeff Cislini General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+26.44%
|
-
|
|
Jan 21
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,406
-5.78%
|
$96,240
$40.5 P/Share
|
|
Dec 18
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,846
+7.98%
|
$0
$0.49 P/Share
|
|
Dec 16
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,329
-3.27%
|
$194,805
$45.4 P/Share
|
|
Dec 16
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,635
-2.66%
|
$118,575
$45.4 P/Share
|
|
Dec 16
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,599
-3.7%
|
$71,955
$45.4 P/Share
|
|
Dec 16
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
4,663
-1.76%
|
$209,835
$45.4 P/Share
|
|
Dec 16
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
11,714
-3.48%
|
$527,130
$45.4 P/Share
|
|
Dec 05
2024
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
1,304,347
+35.29%
|
$59,999,962
$46.0 P/Share
|
|
Nov 15
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,554
-5.6%
|
$140,470
$55.13 P/Share
|
|
Nov 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-2.99%
|
$966,628
$58.97 P/Share
|
|
Nov 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.6%
|
$66,664
$4.09 P/Share
|
|
Nov 06
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-11.62%
|
$360,000
$60.0 P/Share
|
|
Nov 06
2024
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.41%
|
$216,000
$36.57 P/Share
|
|
Nov 04
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+11.23%
|
$175,000
$2.29 P/Share
|
|
Nov 04
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
50,900
-14.5%
|
$2,799,500
$55.56 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-19.67%
|
$550,000
$55.03 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
9,100
-2.94%
|
$500,500
$55.02 P/Share
|
|
Nov 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
9,100
+2.86%
|
$36,400
$4.09 P/Share
|
|
Oct 31
2024
|
Sushil Patel |
SELL
Open market or private sale
|
Direct |
5,000
-20.04%
|
$270,000
$54.14 P/Share
|
|
Oct 31
2024
|
Sushil Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.7%
|
$120,000
$24.84 P/Share
|
|
Oct 14
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-2.99%
|
$816,634
$49.73 P/Share
|
|
Oct 14
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.6%
|
$66,664
$4.09 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-11.62%
|
$300,000
$50.17 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.41%
|
$216,000
$36.57 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.18%
|
$500,000
$50.3 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.41%
|
$20,000
$2.68 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-9.09%
|
$1,500,000
$50.36 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.33%
|
$120,000
$4.09 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-27.42%
|
$2,500,000
$50.34 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.5%
|
$200,000
$4.09 P/Share
|
|
Oct 08
2024
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,200
-28.47%
|
$249,600
$48.02 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-1.62%
|
$450,000
$45.13 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.12%
|
$40,000
$4.09 P/Share
|
|
Sep 16
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,454
-3.09%
|
$63,976
$44.19 P/Share
|
|
Sep 16
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
4,665
-1.73%
|
$205,260
$44.19 P/Share
|
|
Sep 16
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,331
-3.17%
|
$190,564
$44.19 P/Share
|